While the supply is expected to improve dramatically in the coming months, doctors are clamoring for the pills now, not just becausebut because two antibody drugs that were once the go-to treatments don’t work as well against the variant.
“January is going to be a terrible month with a million cases a day,” said University of North Carolina virologist Dr. Myron Cohen. “Most people will do perfectly well, but we have to select out the people who won’t and give them the drugs we have available.”based on studies showing they cut the risk of severe disease and death when given shortly after symptoms appear. They are the first COVID-19 treatments patients can take at home, and thus could reduce the burden on hospitals.
The amount allocated to New York—enough to treat about 20,000 people—is just not enough, said Health Commissioner Dr. Mary Bassett. “We need more of these drugs in order to make them alter the course of the pandemic and reduce hospitalization,” she said. At the UPMC hospital system in Pennsylvania, the staff can treat fewer than 1,000 patients per week with antibodies, down from as many as 4,000 earlier in the pandemic.
MUSKSWAPCHANNEL twitter account is dead, there is no news or anything like that, just looking at it is not good, it makes buyers feel strange, it's definitely a scam, because half of our money has been spent, and he made a new presale on his website, what a good idea very sly
Prioritize the vaccinated and immune compromised. Otherwise there will be nothing left after all the selfish unvaccinated people get COVID and then come crying to hospitals wanting help.
According to data by the HHS_AR, 19 U.S. states currently have free ICU hospital bed capacities diminished to 15 percent or less.
Yeah...okay
The jab costs $20. The Pills cost $500. Get the jab. Save the taxpayer's money.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Independent - 🏆 80. / 59 Read more »
Source: The Guardian - 🏆 84. / 53 Read more »
Source: TheSun - 🏆 64. / 61 Read more »
Source: The Mirror - 🏆 136. / 51 Read more »
Source: The Mirror - 🏆 136. / 51 Read more »
Source: TheEconomist - 🏆 6. / 92 Read more »